Apontis Pharma AG - ESG Rating & Company Profile powered by AI
The analysis of Apontis Pharma AG incorporates data points from across the internet as well as from public documents by Apontis Pharma AG. The analysis of Apontis Pharma AG is assembled by All Street Sevva using proprietary NLP. The SDG score for Apontis Pharma AG indicates the company's transparency towards the United Nations Sustainable Development Goals.
Apontis Pharma AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 2.7, social score of 1.6 and governance score of 6.0.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1186 | Simply Better Brands Corp | 3.5 | Medium |
| 1186 | Yunnan Baiyao Group Co Ltd | 3.5 | Medium |
| 1234 | Apontis Pharma AG | 3.4 | Medium |
| 1234 | Cassava Sciences Inc | 3.4 | Medium |
| 1234 | Brickell Biotech Inc | 3.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Apontis Pharma AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Apontis Pharma AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Apontis Pharma AG report the average age of the workforce?
Sign up for free to unlockDoes Apontis Pharma AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Apontis Pharma AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Apontis Pharma AG disclose cybersecurity risks?
Sign up for free to unlockDoes Apontis Pharma AG offer flexible work?
Sign up for free to unlockDoes Apontis Pharma AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Apontis Pharma AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Apontis Pharma AG conduct supply chain audits?
Sign up for free to unlockDoes Apontis Pharma AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Apontis Pharma AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Apontis Pharma AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Apontis Pharma AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Apontis Pharma AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Apontis Pharma AG disclose water use targets?
Sign up for free to unlockDoes Apontis Pharma AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Apontis Pharma AG have a product recall in the last two years?
Sign up for free to unlockDoes Apontis Pharma AG disclose incidents of discrimination?
Sign up for free to unlockDoes Apontis Pharma AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Apontis Pharma AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Apontis Pharma AG disclose parental leave metrics?
Sign up for free to unlockDoes Apontis Pharma AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Apontis Pharma AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Apontis Pharma AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Apontis Pharma AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Apontis Pharma AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Apontis Pharma AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Apontis Pharma AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Apontis Pharma AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Apontis Pharma AG disclose its waste policy?
Sign up for free to unlockDoes Apontis Pharma AG report according to TCFD requirements?
Sign up for free to unlockDoes Apontis Pharma AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Apontis Pharma AG disclose energy use targets?
Sign up for free to unlockDoes Apontis Pharma AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Apontis Pharma AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Apontis Pharma AG
These potential risks are based on the size, segment and geographies of the company.
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company is headquartered in Monheim am Rhein, Germany.